Corbus Pharmaceuticals
CRBP
#10362
Rank
A$64.13 M
Marketcap
A$3.11
Share price
-15.40%
Change (1 day)
-83.26%
Change (1 year)

EPS for Corbus Pharmaceuticals (CRBP)

EPS in 2026 (TTM): A-$9.14

According to Corbus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$9.35. In 2025 the company made an earnings per share (EPS) of A-$9.03 a decrease over its 2024 EPS that were of A-$5.53.

EPS history for Corbus Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$9.141.12%
2025A-$9.0363.39%
2024A-$5.53
2022A-$15.35-13.16%
2021A-$17.68-73.65%
2020A-$67.0830.97%
2019A-$51.2215.31%
2018A-$44.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Viking Therapeutics
VKTX
A-$8.16-12.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
A-$6.98-25.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
A-$14.64 56.54%๐Ÿ‡บ๐Ÿ‡ธ USA